A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study is designed to assess safety, tolerability, and pharmacokinetics of single ascending doses (SAD) and multiple-ascending doses (MAD) of ABI-6250 in healthy participants. Effect of food will also be evaluated in Part A.
Epistemonikos ID: 5415ab6ba84720f61feee09d9d8ceeee84d6e8b3
First added on: Jan 01, 2025